Market Update Graphic
Source: The Market Online
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up around 1% at 8,210 points.

Counting in the US election is underway and markets are eagerly watching the results trickle in.

All sectors have gained ground and the Discretionary sector has been the best performer, up 1.4%, followed by Utilities, up 1.1% and Financials, up 1.1%.

Company News

Critica (ASX:CRI) has been flat after identifying a large intersection grading 3,075 parts per million (ppm) in total rare earth oxides. The resource is from drilling at its Jupiter target – part of the larger Brothers REE play in WA.

Critica has been 1.2 cents.

Australian Vanadium (ASX:AVL) has been down 3.1% on  kick off of Project Lumina, seeking to build a modular 100MW Vanadium Flow Battery (VFB) for use in Australia.

Australian Vanadium has been 1.6 cents.

Metal Bank (ASX:MBK) has been up 11.8% on news its confirmed its Saudi Arabian-based JV has won a fresh exploration permit in the Kingdom.

The JV, named Consolidated Mining Company (CMC), has been successful in Saudi government-led round 6 licence applications for a copper, zinc and gold project called Wadi Al Junah.

Metal Bank has been 1.9 cent.

More From The Market Online
HotCopper Daily Market Trends Graphic

Monday’s HotCopper trends: Electro Optic, BPH, and other daily topics | Jan 12

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front
Lawsuit market concept

GreenX Metals surges +16% as Singaporean court lights way to $380M payout from Poland

GreenX has rocketed more than +15% as a court in Singapore dismissed a trade appeal from…

‘Major scope to keep growing’: Leeuwin’s next Marda drilling to extend mineralisation, increase resource

Drills are firing at Marda again, with Leeuwin Metals restarting its exploration work in Western Australia…
FDA Approval

Imricor Medical Systems runs hard on FDA greenlight for diagnostic catheter

Imricor has won its first keystone FDA clearance, with the U.S. regulator effectively thumbs-upping Imricor's diagnostic…